Interim CEO and CFO of CorMedix Inc. (U.S.: Nasdaq:CRMD), David Matthew T, buys 1,000 shares worth $5,070
According to CorMedix Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 19 09:53 AM, company Interim CEO and CFO, David Matthew T disclosed buying 1,000 shares at a cost of $5.07. At the time of this transaction (Nov 17), this trade was worth $5,070 in total. As of Nov 17, David Matthew T now owns 2,150 shares in total worth about $11,008.0.
For the last few recent trades made by CorMedix Inc. (U.S.: Nasdaq:CRMD) Interim CEO and CFO, David Matthew T, we have the following information:
- SEC Form 4 filing: Sep 03: Bought 1,150 shares at the rate of $4.07 per share. Total worth of this trade was $4,680. Total number of shares owned as of Sep 03 were 1,150
Posted by
George Daniels
on Friday November 19 2021, 10:40 AM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
